The on-demand edition of the latest in Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting.

Omar Ali and Adam Meads discuss current perceptions of payment-over-time models when thinking about alternative financing for Gene Therapies, collected directly from US payer interviews (National Plan, Regional Plan, IDN, Employer Coalition Organization) conducted by Verpora in 2023. They explore what these payers are saying about warranty schemes, explore a case study of Roctavian for Severe Hemophilia A, and the current perceptions of barriers for IC and the future of IC in the U.S.

Plus, an update on the Value Based Healthcare landscape in Brazil, and an overview of Innovative Contracting, its benefits and challenges, and importance to the industry.

Speakers

Omar Ali
Head of Payers, Verpora
LinkedIn

Adam Meads
Head of Research & Analytics, Verpora
LinkedIn

Harry Osborn
Account Director, Verpora
LinkedIn